Literature DB >> 8250903

A single protein immunologically identified as CD38 displays NAD+ glycohydrolase, ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase activities at the outer surface of human erythrocytes.

E Zocchi1, L Franco, L Guida, U Benatti, A Bargellesi, F Malavasi, H C Lee, A De Flora.   

Abstract

The three ectoenzyme activities, NAD+ glycohydrolase, ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase were purified to homogeneity from solubilized human erythrocyte membranes. The purification procedure involved three sequential chromatography steps on hydroxylapatite, immobilized Cu++ and immobilized anti-CD38 monoclonal antibody resins. The final step yielded a single 46 kDa protein displaying all three enzymatic activities. Since the protein bound specifically to the anti-CD38 resin, it was immunologically identified as CD38, a 46 kDa surface antigen involved in activation and proliferation of lymphocyte populations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8250903     DOI: 10.1006/bbrc.1993.2416

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  70 in total

1.  CD38 expression in early B-cell precursors contributes to extracellular signal-regulated kinase-mediated apoptosis.

Authors:  Héctor Romero-Ramírez; Monserrat Teresa Morales-Guadarrama; Rosana Pelayo; Rubén López-Santiago; Leopoldo Santos-Argumedo
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

2.  Identification of bovine liver mitochondrial NAD+ glycohydrolase as ADP-ribosyl cyclase.

Authors:  M Ziegler; D Jorcke; M Schweiger
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

3.  Generation of cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate by CD38 for Ca2+ signaling in interleukin-8-treated lymphokine-activated killer cells.

Authors:  So-Young Rah; Mazhar Mushtaq; Tae-Sik Nam; Suhn Hee Kim; Uh-Hyun Kim
Journal:  J Biol Chem       Date:  2010-05-04       Impact factor: 5.157

4.  Critical role for NAD glycohydrolase in regulation of erythropoiesis by hematopoietic stem cells through control of intracellular NAD content.

Authors:  Tae-Sik Nam; Kwang-Hyun Park; Asif Iqbal Shawl; Byung-Ju Kim; Myung-Kwan Han; Youngho Kim; Joel Moss; Uh-Hyun Kim
Journal:  J Biol Chem       Date:  2014-04-23       Impact factor: 5.157

5.  Murine B-cell activation via CD38 and protein tyrosine phosphorylation.

Authors:  P A Kirkham; L Santos-Argumedo; M M Harnett; R M Parkhouse
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

6.  CD38 expression as response of hematopoietic system to cancer.

Authors:  Işil Albeniz; Ozlem Demir-Coşkun; Leyla Türker-Şener; Aycan Baş; Oktar Asoğlu; Rüstem Nurten
Journal:  Oncol Lett       Date:  2011-05-16       Impact factor: 2.967

7.  Inhibition of the intrinsic NAD+ glycohydrolase activity of CD38 by carbocyclic NAD analogues.

Authors:  K A Wall; M Klis; J Kornet; D Coyle; J C Amé; M K Jacobson; J T Slama
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

8.  CD38 and CD157 ectoenzymes mark cell subsets in the human corneal limbus.

Authors:  Alberto L Horenstein; Federico Sizzano; Riccardo Lusso; Federico Genzano Besso; Enza Ferrero; Silvia Deaglio; Franco Corno; Fabio Malavasi
Journal:  Mol Med       Date:  2008-11-19       Impact factor: 6.354

9.  Isolation of hematopoietic stem cells and the effect of CD38 expression during the early erythroid progenitor cell development process.

Authors:  Işil Albenız; Leyla Türker-Şener; Aycan Baş; Ibrahim Kalelıoğlu; Rüstem Nurten
Journal:  Oncol Lett       Date:  2011-10-21       Impact factor: 2.967

10.  Decreased ADP-ribosyl cyclase activity in peripheral blood mononuclear cells from diabetic patients with nephropathy.

Authors:  Michio Ohtsuji; Kunimasa Yagi; Miyuki Shintaku-Kubota; Yukiko Kojima-Koba; Naoko Ito; Masako Sugihara; Naoto Yamaaki; Daisuke Chujo; Atsushi Nohara; Yoshiyu Takeda; Junji Kobayashi; Masakazu Yamagishi; Haruhiro Higashida
Journal:  Exp Diabetes Res       Date:  2009-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.